Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers. These devices are primarily used in health care facilities for 
Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia's proprietary AI drug discovery platform and drug design know-how with Bayer's data and drug discovery capabilities. 
Is it possible to screen thousands of people for tuberculosis using artificial intelligence in a country where internet barely exists? It is with CAD4TB. As of October, this innovative software is used to screen people for TB in even the remotest areas of Eritrea. It has been developed by Dutch company Thirona in collaboration with the also Dutch Delft Imaging Systems. Bayer is transforming its IT function to further accelerate the digitalization of the company. Leading IT providers will take over standardized services, such as the provision of digital workplaces for employees or the global operation of IT infrastructure. Internally, the IT function will focus on differentiating solutions for Bayer's businesses. 
Owkin, which is developing Federated Learning and AI technologies to advance medical research, announces it is teaming up with technology company NVIDIA and King's College London (KCL) to deliver Federated Learning in the healthcare and life sciences sector. 
ANCILE Solutions is bringing its content creation and in-app learning tool, uPerform, to the UK health sectorto support NHS organisations with the deployment and adoption of major IT systems.
ANCILE Solutions already delivers uPerform to 4,600 global customers, who use it to train and support users on 200 of the world’s leading business and healthcare applications.